Literature DB >> 9564643

Midtrimester amniocentesis. Influence of operator caseload on sampling efficiency.

R K Silver1, T L Russell, M P Kambich, E A Leeth, S N MacGregor, J S Sholl.   

Abstract

OBJECTIVE: To evaluate the impact of operator caseload on the sampling efficiency for early and standard, midtrimester amniocentesis. STUDY
DESIGN: Prospective ascertainment of genetic amniocenteses performed during 36 months, grouped into early (13-14 weeks' gestation) and standard procedures (15-20 weeks' gestation). Details of each amniocentesis were recorded immediately after sampling, and pregnancy outcomes were retrieved via questionnaires completed by the delivering physician. Sampling efficiency was evaluated separately in the early and standard cohorts in relation to operator caseload.
RESULTS: In total, 193 and 707 patients underwent early and standard amniocentesis, respectively. Forty of 46 physician-operators performed < 50 total procedures during the study interval (group A). When compared to operators performing > or = 50 cases (group B, n = 6), a higher rate of single-pass success was noted among group B physicians for both early and standard procedures (A vs. B, early: 40/45 vs. 145/148, P = .018; standard: 243/295 vs. 384/412, P < .0001). Logistic regression confirmed an independent effect of physician caseload on sampling efficiency and a significant interaction between physician caseload and simultaneous ultrasound guidance in predicting single-attempt success.
CONCLUSION: Operator caseload directly influenced sampling efficiency for both early and standard, midtrimester amniocentesis.

Entities:  

Mesh:

Year:  1998        PMID: 9564643

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  1 in total

1.  Randomised experimental comparison of 23G versus 22G needle for ultrasound guided invasive fetal procedures.

Authors:  R Devlieger; P N Adama van Scheltema; D Oepkes
Journal:  Facts Views Vis Obgyn       Date:  2010
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.